Regenera Pharma Ltd. announced that it will receive a round of funding on December 18, 2016. The company will issue convertible loan in the transaction. The transaction will include participation from existing investor InterCure Ltd. (TASE:INCR) and a lead investor. The existing shareholders will participate for $5 million which will include InterCure Ltd. and a lead investor for $0.35 million each. The second tranche expected for January 15, 2016, will include InterCure Ltd. and the lead investor to invest up to $1.65 million each.